InvestorsHub Logo
Followers 43
Posts 4926
Boards Moderated 0
Alias Born 08/25/2000

Re: None

Friday, 01/26/2018 5:20:45 PM

Friday, January 26, 2018 5:20:45 PM

Post# of 32016
Pile: Thanks to an overzealous, and very crowded, trade on the short side, MannKind has become the most extreme example of "market inefficiency" I have seen in my 30 years of following the biotech sector. Although the shorts have been in control for some time now, history suggests that this "extreme mispricing of assets" cannot go on forever. With a number of potential catalysts on the near-term horizon, it was a logical choice to add more while the stock is still cheap.

https://www.forbes.com/sites/kenkam/2018/01/26/nate-pile-sells-some-nvidia-buys-more-mannkind-apple-and-celgene/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo#48dc546c3c0f

All my posts are in my opinion only,do your own DD and don't spend more then you can afford to lose

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News